Stroke in young patients with hyperhomocysteinemia due to cystathionine beta-synthase deficiency

Neurology

Volumn 60, Issue 2, 2003, Pages 275-279

  Kelly, P J ^a   Furie, K L ^b   Kistler, J P ^b   Barron, M ^b   Picard, E H ^b   Mandell, R ^b   Shih, V E ^b  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

5,10 METHYLENETETRAHYDROFOLATE REDUCTASE (FADH2); CYSTATHIONINE BETA SYNTHASE; GENE PRODUCT; RESTRICTION ENDONUCLEASE;

ADULT; ARTERY EMBOLISM; ARTICLE; CASE REPORT; CLINICAL FEATURE; DISEASE ASSOCIATION; DISEASE COURSE; DISEASE PREDISPOSITION; ENZYME DEFECT; FEMALE; FLUORESCENCE POLARIZATION; GENE MUTATION; GENETIC ANALYSIS; GENOTYPE; HETEROZYGOSITY; HOMOCYSTINURIA; HUMAN; HYPERHOMOCYSTEINEMIA; IMMUNOASSAY; ION EXCHANGE CHROMATOGRAPHY; MALE; ONSET AGE; PATHOGENESIS; PHENOTYPE; PRIORITY JOURNAL; RESTRICTION MAPPING; RISK FACTOR; SEQUENCE ANALYSIS; STROKE; VEIN THROMBOSIS;

EID: 0037469194     PISSN: 00283878     EISSN: None     Source Type: Journal    
DOI: 10.1212/01.WNL.0000042479.55406.B3     Document Type: Article

References (23)

1. Mudd SH, Finkelstein JD, Refsum H, et al. Homocysteine and its disulfide derivatives: a consensus terminology. Arterioscler Thromb Vasc Biol 2000;20:1704-1706.
2. Mudd SH, Levy HL, Kraus JP. Disorders of transsulfuration. In: Scriver CR, Beaudet AL, Sly WS, Valle D. The metabolic and molecular basis of inherited disease, 8th ed, vol 2. New York: McGraw-Hill, 2001.
3. Kelly PJ, Rosand J, Plomaritoglou A, Chang Y, Kistler JP, Furie KL. Hyperhomocyst(e)inemia and risk of stroke: results of a meta-analysis. Neurology 2002;59:529-536.
4. Selhub J, Jacques PF, Bostom AG, et al. Association between plasma homocysteine concentrations and extracranial carotid-artery stenosis. N Engl J Med 1995;332:286-291.
5. Shipchandler MT, Moore EG. Rapid, fully automated measurement of plasma homocyst(e)ine with the Abbot IMx analyzer. Clin Chem 1995;41:991-998.
6. Fowler B, Kraus J, Packman S, Rosenberg LE. Homocystinuria: evidence for three distinct classes of cystathionine beta-synthase mutants in cultured fibroblasts. J Clin Invest 1978;61:645-653.
7. Hu FL, Gu Z, Kozich V, Draus JP, Ramesh V, Shih VE. Molecular basis of cystathionine beta-synthase deficiency in pyridoxine responsive and unresponsive homocystinuria. Hum Mol Genet 1993;2:1857-1860.
8. Shih VE, Fringer JM, Mandell R, et al. A missense mutation (I278T) in the cystathionine beta-synthase gene prevalent in pyridoxineresponsive homocystinuria and associated with mild clinical phenotype. Am J Hum Genet 1995;57:34-39.
9. Frosst P, Blom HJ, Milos R, et al. A candidate genetic risk factor for vascular disease: a common mutation in methylenetetrahydrofolate reductase. Nat Genet 1995;10:111-113.
10. Simioni P, Prandoni P, Lensing AW, et al. The risk of recurrent venous thromboembolism in patients with an Arg506->Gln mutation in the gene for factor V (factor V Leiden). N Engl J Med 1997;336:399-403.
11. Schievink WI. Spontaneous dissection of the carotid and vertebral arteries. N Engl J Med 2001;344:898-906.
12. Gallai V, Caso V, Paciaroni M, et al. Mild hyperhomocyst(e)inemia: a possible risk factor for cervical artery dissection. Stroke 2001;32:714-718.
13. Pezzini A, Del Zotto E, Archetti S, et al. Plasma homocysteine concentration, C677T MTHFR genotype, and 844ins68bp CBS genotype in young adults with spontaneous cervical artery dissection and atherothrombotic stroke. Stroke 2002;33:664-669.
14. Lezak M, ed. Neuropsychological assessment, 3rd ed. New York: Oxford Press, 1995.
15. Wolf PA, Sila CA. Cerebral ischemia with mitral valve prolapse. Am Heart J 1987;113:1308-1315.
16. Gallagher PM, Ward P, Tan S, et al. High frequency of cystathionine beta-synthase mutation G307S in Irish homocystinuria patients. Hum Mutat 1995;6:177-180.
17. Welch GN, Loscalzo J. Homocysteine and atherothrombosis. N Engl J Med 1998;338:1042-1050.
18. Davi G, Di Minno G, Coppola A, et al. Oxidative stress and platelet activation in homozygous homocystinuria. Circulation 2001;104:1124-1128.
19. D'Angelo A, Selhub J. Homocysteine and thrombotic disease. Blood 1997;90:1-11.
20. Wilcken DEL, Wilcken B. The natural history of vascular disease in homocystinuria and the effects of treatment. J Inher Metab Dis 1997;20:295-300.
21. Mudd SH, Skovby F, Levy HL, et al. The natural history of homocystinuria due to cystathionine beta-synthase deficiency. Am J Hum Genet 1985;37:1-31.
22. Den Heijer M, Koster T, Blom HJ, et al. Hyperhomocysteinemia as a risk factor for deep-vein thrombosis. N Engl J Med 1996;334:759-762.
23. Mandel H, Brenner B, Berant M, et al. Coexistence of hereditary homocystinuria and factor V Leiden: effect on thrombosis. N Engl J Med 1996;334:763-768.